Pau d'Arco (Tabebuia impetiginosa) and Autoimmune Diseases: What PubMed Studies Show

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Pau d'Arco (Tabebuia impetiginosa) and Autoimmune Diseases: What PubMed Studies Show

PubMed is the primary database of biomedical literature maintained by the National Library of Medicine. This page describes what PubMed-indexed research reveals about Pau d'Arco (Tabebuia impetiginosa) in the context of Autoimmune Diseases. This is a research summary — not medical advice. Consult your rheumatologist or immunologist.

Volume of Available Research

As of 2026, PubMed contains dozens of relevant publications when searching for "Pau d'Arco (Tabebuia impetiginosa)" combined with "Autoimmune Diseases". The current evidence level derived from this literature is: In vitro anti-cancer activity; very limited clinical data; historical use for immune support

Types of Studies Available

Given the scientific interest in this combination, the published literature includes a range of study types:

  • In vitro (cell culture) studies: Laboratory investigations of Pau d'Arco (Tabebuia impetiginosa) effects on Autoimmune Disease-relevant cell lines
  • In vivo (animal) studies: Preclinical models examining effects on disease pathways
  • Review articles: Systematic reviews and meta-analyses synthesizing available evidence
  • Clinical studies: Human data from case reports, cohort studies, or clinical trials

How to Search PubMed Yourself

To find the most current and complete literature, use these PubMed search strategies:

  • Basic search: Pau d'Arco (Tabebuia impetiginosa) Autoimmune Diseases
  • Advanced search: (Pau d'Arco (Tabebuia impetiginosa)[Title/Abstract]) AND (Autoimmune Diseases[Title/Abstract])
  • Filter by article type: Select "Clinical Trial" to focus on human studies
  • Sort by: Most Recent to see latest publications

Interpreting PubMed Results

When reviewing PubMed studies for Pau d'Arco (Tabebuia impetiginosa) and Autoimmune Disease, key considerations include:

  • Study design hierarchy: RCTs > cohort studies > case-control > case reports > animal studies > cell culture
  • Sample size: Small studies (n<50) should be interpreted cautiously
  • Conflict of interest: Check funding sources
  • Replication: Single studies should not change treatment decisions

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

How many PubMed studies exist on Pau d'Arco (Tabebuia impetiginosa) for Autoimmune Disease?

The exact count changes as new research is published. Search pubmed.ncbi.nlm.nih.gov for 'Pau d'Arco (Tabebuia impetiginosa) AND Autoimmune Diseases' to get the current count. The evidence level from available literature is: In vitro anti-cancer activity; very limited clinical data; historical use for immune support.

Are there PubMed clinical trial results for Pau d'Arco (Tabebuia impetiginosa) in Autoimmune Disease?

To find clinical trial publications: go to PubMed, search 'Pau d'Arco (Tabebuia impetiginosa) Autoimmune Disease', then use the 'Article type' filter to select 'Clinical Trial'. Some clinical data exists for this combination.

Can I access the full text of Pau d'Arco (Tabebuia impetiginosa) + Autoimmune Disease studies for free?

Many NIH-funded studies are available free via PubMed Central (PMC). For paywalled articles, try: the author's institution page, ResearchGate, or emailing the corresponding author directly. Some patients also access papers through their hospital library or university networks.